After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of Century Therapeutics Inc is $42.18M. A total of 0.92 million shares were traded on the day, compared to an average of 948.31K shares.
In the most recent transaction, Carr Douglas sold 296 shares of IPSC for 0.53 per share on Aug 04 ’25. After the transaction, the SVP Finance & Operations now owns 405,686 company shares. In a previous transaction on Jun 09 ’25, Carr Douglas sold 4,904 shares at 0.62 per share. IPSC shares that SVP Finance & Operations owns now total 405,982.
Among the insiders who sold shares, Farid Adrienne disposed of 552 shares on Jun 09 ’25 at a per-share price of $0.62. This resulted in the Chief Operations Officer holding 250,141 shares of IPSC after the transaction. In another insider transaction, Pfeiffenberger Brent sold 475 shares at $0.62 per share on Jun 09 ’25. Company shares held by the President and CEO now total 1,681,783.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, IPSC has a high of $2.05 and a low of $0.34.
As of this writing, IPSC has an earnings estimate of -$0.38 per share for the current quarter. EPS was calculated based on a consensus of 2.0 estimates, with a high estimate of -$0.35 per share and a lower estimate of -$0.4. The company reported an EPS of -$0.38 in the last quarter
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. IPSC’s latest balance sheet shows that the firm has $222.88M in Cash & Short Term Investments as of fiscal 2021. There were $25.12M in debt and $15.65M in liabilities at the time. Its Book Value Per Share was $2.79, while its Total Shareholder’s Equity was $396.24M.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for IPSC is Buy with a score of 4.67.
